Dagang NeXchange Berhad Annual Report 2024

3. RECURRENT RELATED PARTY TRANSACTIONS During the FYE 31 December 2024, the Company did not enter into any recurrent related party transaction that requires the shareholders’ mandate. 4. MATERIAL CONTRACTS Save as disclosed in the Audited Financial Statements for the FYE 31 December 2024, there were no material contracts entered into by the Company and DNeX Group involving the interests of directors, chief executive who is not a director or major shareholders, either still subsisting at the end of the FYE 31 December 2024 or entered since the end of the previous financial period. 5. CONTRACTS RELATING TO LOANS During the FYE 31 December 2024, there were no material contracts relating to loans entered by the Company and its subsidiaries involving the directors, chief executive who is not a director or major shareholders. 6. EMPLOYEES’ SHARE OPTION SCHEME (“ESOS”) The Company had, during its Extraordinary General Meeting held on 1 April 2021, obtained shareholders’ approval in relation to the implementation of an ESOS of up to 5% of the total number of issued shares of the Company (excluding treasury shares, if any) at any point in time over the duration of the ESOS for the eligible directors and employees of the Company and its subsidiaries (excluding dormant subsidiaries). The ESOS shall be in force for five (5) years from the implementation date of 6 April 2021, and this is the only ESOS in existence during the FYE 31 December 2024. During the FYE 31 December 2024, no new ordinary shares were issued and allotted pursuant to the exercise of the ESOS options. Brief details on the number of ESOS options granted, exercised, forfeited and outstanding since commencement on 6 April 2021 to 31 December 2024 are set out in the tables below: Since the implementation of the ESOS Description Number of Options Granted 76,626,800 Exercised 1,047,750 Not Accepted 5,089,500 Forfeited 24,319,250 Outstanding 46,170,300 95 Governance DAGANG NeXCHANGE BERHAD Integrated Report 2024 ADDITIONAL COMPLIANCE INFORMATION

RkJQdWJsaXNoZXIy NDgzMzc=